International audienceAlzheimer's disease (AD) is characterised by macroscopic cerebral damages which can be studied in vivo with neuroimaging techniques, even at the earliest stage. Studies were conducted in patients with amnestic Mild Cognitive Impairment (MCI) who best represent incipient AD. Right temporo-parietal hypometabolism, assessed by resting-state (18)FDG-PET, distinguishes patients who further develop AD from those who remain stable. From the pre-dementia stage of MCI, atrophy of the hippocampal region detected with structural MRI contrasts with functional alteration of the posterior cingulate gyrus measured with (18)FDG-PET and SPECT. Results from resting-state fMRI confirm this pattern of functional abnormalities and highligh...
The clinical construct of mild cognitive impairment (MCI) identifi es a syndrome of cognitive defi c...
Structural magnetic resonance imaging (MRI) studies of Alzheimer’s disease and mild cognitive impair...
In July of 1998, at the Amsterdam meeting of the International Alzheimer's Disease Congress, the fir...
International audienceAlzheimer's disease (AD) is characterised by macroscopic cerebral damages whic...
Early diagnosis of Alzheimer’s disease (AD) is indispensable for the future success of disease-...
Abstract Several neuroimaging techniques are promising tools as early markers of brain pathology in ...
Alzheimer disease (AD), the most common cause of dementia in the elderly, is a progressive neurodege...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...
Of the many laboratory measures and techniques available for understanding and quantifying biologica...
We explored resting-state metabolic connectivity in prodromal Alzheimer's disease (pAD) patients and...
Aim of this study was to investigate the functional compensation mechanism in incipient Alzheimer's ...
There is a growing need for biomarkers of Alzheimer's Disease (AD) to aid in early detection, tracki...
peer reviewedAlzheimer's disease is characterized by early hippocampal lesions, but neuropathologica...
Positron emission tomography in Alzheimer's disease (AD) demonstrates a metabolic decrease, predomin...
International audienceIn early Alzheimer's disease (AD), the hippocampal region is the area most sev...
The clinical construct of mild cognitive impairment (MCI) identifi es a syndrome of cognitive defi c...
Structural magnetic resonance imaging (MRI) studies of Alzheimer’s disease and mild cognitive impair...
In July of 1998, at the Amsterdam meeting of the International Alzheimer's Disease Congress, the fir...
International audienceAlzheimer's disease (AD) is characterised by macroscopic cerebral damages whic...
Early diagnosis of Alzheimer’s disease (AD) is indispensable for the future success of disease-...
Abstract Several neuroimaging techniques are promising tools as early markers of brain pathology in ...
Alzheimer disease (AD), the most common cause of dementia in the elderly, is a progressive neurodege...
F FDG-PET) has gained a leading role in the diagnostic assessment of patients with cognitive complai...
Of the many laboratory measures and techniques available for understanding and quantifying biologica...
We explored resting-state metabolic connectivity in prodromal Alzheimer's disease (pAD) patients and...
Aim of this study was to investigate the functional compensation mechanism in incipient Alzheimer's ...
There is a growing need for biomarkers of Alzheimer's Disease (AD) to aid in early detection, tracki...
peer reviewedAlzheimer's disease is characterized by early hippocampal lesions, but neuropathologica...
Positron emission tomography in Alzheimer's disease (AD) demonstrates a metabolic decrease, predomin...
International audienceIn early Alzheimer's disease (AD), the hippocampal region is the area most sev...
The clinical construct of mild cognitive impairment (MCI) identifi es a syndrome of cognitive defi c...
Structural magnetic resonance imaging (MRI) studies of Alzheimer’s disease and mild cognitive impair...
In July of 1998, at the Amsterdam meeting of the International Alzheimer's Disease Congress, the fir...